F03925 – Pneumococcal Vaccine Trial
Fusion Clinical Research Norwood
Adults aged 50–64 may be eligible for a clinical trial evaluating an investigational pneumococcal vaccine.
The study includes 6 visits and one telephone call over 6 months. Participants receive compensation for their time.
Sign up below to see if you qualify.
Eligibility requirements
- Age: 50-64
- Sex: M & F
- BMI: Less than 40kg/m2
- Medication: Cannot have received any pneumococcal vaccine previously. Cannot be taking immune-modifying drugs.
- Medical History: Eligibility requirements (not limited to): Adults aged 50–64, In good health or with stable medical conditions. No history of serious pneumococcal infection in the past 3 years. Not immunocompromised. Cannot have had prior adverse reaction or hypersensitivity to vaccines. Cannot have a hypersensitivity to latex.
Overnight Stays
- Nil
Outpatient Visits
- 6 visits and one telephone call over 6 months.
Payment/Remuneration
- $250 for each study visit, plus $10 per day of eDiary completion. There is also a scheduled phone call at Visit 6 which you will receive $35 for completion.
How to apply
To register your interest in this trial, please complete the form below, or call us on 1800-FUSION (1800 387 466). A Fusion team member will be in contact to discuss your eligibility shortly.